Revolutionize Drug Development with AI Mastery.
Step into the future of pharmaceuticals with the MS in AI for Drug Development program. Harness cutting-edge technologies like natural language processing and machine learning to accelerate innovation at every stage of drug development.
From strategic planning to clinical trial optimization, this program empowers professionals to lead the transformation of health care. Unlock the potential of AI and position yourself as a trailblazer in health care.
Applications are reviewed on a rolling basis and must be submitted by July 15.
Watch this short video that features an interview with Joga Gobburu, PhD, MBA, professor in the Department of Practice, Sciences, and Health Outcomes Research, to learn more about the MS in AI for Drug Development program at the University of Maryland School of Pharmacy.
The MS in AI for Drug Development (AIDD) program is designed for professionals with bachelor's, master's, or terminal degrees who aspire to transform into decision-making data scientists in pharmaceutical, biotechnology or government institutions.
Graduates of the MS in AIDD will:
- Apply advanced AI and analytical techniques to streamline drug development and clinical trials.
- Build and lead high-performance teams equipped with next-generation problem-solving capabilities.
- Shape strategic decisions in pharmaceutical innovation with a data-driven mindset.
The program is particularly well-suited for professionals in areas such as:
- Pharmaceutical or biotechnology industry
- Government agencies
- Engineering
- Statistics
- Data sciences
- Pharmaceutical sciences
- Epidemiology
Students enrolled in the MS in AI for Drug Development program can study at their own pace, and choose to complete the 30-credit program in four or seven semesters.
Explore the four-semester course of study and seven-semester course of study outlines to help determine which option might best fit your unique goals. No matter which choice you select, as a graduate of the School of Pharmacy's MS in AI for Drug Development program, you will be highly sought after by pharmaceutical companies, biotechnology firms, and other research organizations.
The role of artificial intelligence (AI) in drug development is transformative, enhancing the capabilities of pharmaceutical leaders and researchers. The MS in AIDD was designed for professionals who want to transition into decision-making data scientists in pharmaceutical, biotechnology, or government institutions.
Joga Gobbura, PhD, MBA, Director, MS in AI for Drug DevelopmentThe MS in AI for Drug Development program is the only one of its kind in the world. Students can immediately apply the skills learned in the program to real-world situations, better positioning them for accelerated professional growth.
As a graduate of the MS in AI for Drug Development program, you will be equipped to harness the power of AI in the drug development process.
Learn what you need to complete your online application and take the first step to advancing your career in Artificial Intelligence. Applications for the MS in AI for Drug Development program are reviewed on a rolling basis, but must be submitted by July 15.
Apply Today